Yesterday (September 17, 2019), the US Food and Drug Administration approved apalutamide (Erleada) for treatment of men with metastatic castration-sensitive prostate cancer (mCSPC) … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: apalutamide, approval, Erleada, mCSPC, mHSPC, US | Leave a comment »
According to a new set of projections just published in The Lancet this morning, the total global burden of new cases of cancer will increase by about 75 percent (from 12.7 million in 2008 to 22.2 million in 2030) over the next 30-odd years. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: 2030, future, global, incidence, US | 4 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 